Drug Trial Radar · NCT03000712
Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC Comared to Negative Control After High Tibial Osteotomy in the Osteoarthritis Patients.
Last checked: Nov 19, 2026Latest source record: Jan 29, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
26
Actual
Start
Nov 2, 2016
Primary completion
May 22, 2020
Study completion May 22, 2020
Sponsor
- Lead sponsor
- R-BioIndustry
- Sponsor type
- Industry
- First posted
- Dec 22, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 20 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of intra-articular injection of autologous adipose tissue derived mesenchymal stem cells compared after high tibial osteotomy to negative control in the osteoarthritis patients
Conditions
- Degenerative Arthritis
- Knee Osteoarthritis
Interventions
Autologous Adipose Tissue derived MSCs 1x10^8cells/3mlBiological
biological : Autologous Adipose Tissue derived MSCs 1x10\^8cells/3ml drug: saline solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- MRI scanTime frame: 24 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
KyungHee University Gangdong Hospital
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.